Buhmann C - Search Results

1

Blood-based biomarker in Parkinson's disease: potential for future applications in clinical research and practice.

Tönges L, Buhmann C, Klebe S, Klucken J, Kwon EH, Müller T, Pedrosa DJ, Schröter N, Riederer P, Lingor P. Tönges L, et al. Among authors: buhmann c. J Neural Transm (Vienna). 2022 Sep;129(9):1201-1217. doi: 10.1007/s00702-022-02498-1. Epub 2022 Apr 15. J Neural Transm (Vienna). 2022. PMID: 35428925 Free PMC article. Review.

2

Workshop II: "neuroprotection"--the Lugano consensus.

Riederer P, Brücke T, Buhmann C, Müller T, Schwartz A, Storch A, Winner B. Riederer P, et al. Among authors: buhmann c. J Neurol. 2000 Sep;247 Suppl 4:IV/36-7. doi: 10.1007/pl00007774. J Neurol. 2000. PMID: 11199817 Review.

3

COMT-inhibition increases serum levels of dihydroxyphenylacetic acid (DOPAC) in patients with advanced Parkinson's disease.

Oechsner M, Buhmann C, Strauss J, Stuerenburg HJ. Oechsner M, et al. Among authors: buhmann c. J Neural Transm (Vienna). 2002;109(1):69-75. doi: 10.1007/s702-002-8237-z. J Neural Transm (Vienna). 2002. PMID: 11793163

4

CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity.

Ganzer S, Arlt S, Schoder V, Buhmann C, Mandelkow EM, Finckh U, Beisiegel U, Naber D, Müller-Thomsen T. Ganzer S, et al. Among authors: buhmann c. J Neural Transm (Vienna). 2003 Oct;110(10):1149-60. doi: 10.1007/s00702-003-0017-7. J Neural Transm (Vienna). 2003. PMID: 14523627

5

[When should we start medical treatment in Parkinson disease].

Buhmann C, Klucken J, Korchounov A, Schwarz M, Vieregge P, Jost WH. Buhmann C, et al. Fortschr Neurol Psychiatr. 2010 Mar;78 Suppl 1:S31-3. doi: 10.1055/s-0029-1245169. Epub 2010 Mar 1. Fortschr Neurol Psychiatr. 2010. PMID: 20195939 Review. German.

6

Wearable sensor-based objective assessment of motor symptoms in Parkinson's disease.

Ossig C, Antonini A, Buhmann C, Classen J, Csoti I, Falkenburger B, Schwarz M, Winkler J, Storch A. Ossig C, et al. Among authors: buhmann c. J Neural Transm (Vienna). 2016 Jan;123(1):57-64. doi: 10.1007/s00702-015-1439-8. Epub 2015 Aug 8. J Neural Transm (Vienna). 2016. PMID: 26253901 Review.

7

The impact of Parkinson disease on patients' sexuality and relationship.

Buhmann C, Dogac S, Vettorazzi E, Hidding U, Gerloff C, Jürgens TP. Buhmann C, et al. J Neural Transm (Vienna). 2017 Aug;124(8):983-996. doi: 10.1007/s00702-016-1649-8. Epub 2016 Nov 16. J Neural Transm (Vienna). 2017. PMID: 27853927

8

Levodopa/carbidopa intestinal gel (LCIG) infusion as mono- or combination therapy.

Buhmann C, Hilker R, Lingor P, Schrader C, Schwarz J, Wolz M, Reichmann H. Buhmann C, et al. J Neural Transm (Vienna). 2017 Aug;124(8):1005-1013. doi: 10.1007/s00702-017-1698-7. Epub 2017 Feb 22. J Neural Transm (Vienna). 2017. PMID: 28229223

9

[Parkinson Disease and Pain - diagnostic and therapeutic approaches to a challenging non-motor symptom].

Buhmann C, Ip CW, Oehlwein C, Tönges L, Wolz M, Reichmann H, Kassubek J. Buhmann C, et al. Fortschr Neurol Psychiatr. 2018 Sep;86(S 01):S48-S58. doi: 10.1055/a-0590-4464. Epub 2018 Jul 17. Fortschr Neurol Psychiatr. 2018. PMID: 30016807 Review. German.

10

The Hamburg Parkinson day-clinic: a new treatment concept at the border of in- and outpatient care.

Fründt O, Mainka T, Schönwald B, Müller B, Dicusar P, Gerloff C, Buhmann C. Fründt O, et al. Among authors: buhmann c. J Neural Transm (Vienna). 2018 Oct;125(10):1461-1472. doi: 10.1007/s00702-018-1918-9. Epub 2018 Aug 22. J Neural Transm (Vienna). 2018. PMID: 30167934

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

163 results

Search Page